推荐应用
Human LILRA3, also known as Leukocyte Ig-like receptor 4 (LIR-4), CD85 antigen-like family member E, Immunogobulin-like transcript 6 (ILT-6) and monocyte inhibitory receptor HM43/HM31, is a 70 kD Ig superfamily member that belongs to the leukocyte receptor complex/cluster. Mature LILRA3 is 416 amino acids (aa) in length and contains four C2-type Ig-like domains. Unlike other LILR family members, LILRA3 is actively secreted. Alternative splicing generates additional isoforms with one containing an extra 18 aa in the signal peptide and/or a 64 amino acid deletion in the C-terminal half of the second Ig-like domain. Human LILRA3 shares ~86% aa identity with Chimpanzee LILRA3. Human LILRA3 acts as a soluble receptor for class I MHC antigens. It binds both classical and non‑classical HLA class I molecules but with reduced affinities compared to LILRB1 or LILRB2.
高纯度、高活性、低内毒素、高批间一致性
产品数据

-25 ~ -15℃保存,收到货之后有效期1年。 复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。
【应用方向】免疫检查点核心家族:B7-CD28超家族蛋白
382
2026-04-21
【应用方向】TIM-3:下一代肿瘤免疫检查点治疗的核心靶点
304
2026-04-21
【应用方向】SIRP家族分子详解与产品选择指南
279
2026-04-21
【应用方向】OX40-OX40L共刺激轴的T细胞存活调控
315
2026-04-21
【应用方向】LILRB家族:髓系细胞免疫检查点的研究前沿与产品解决方案
366
2026-04-21
【应用方向】LAG-3(CD223):T细胞耗竭调控网络的核心节点
310
2026-04-21
【应用方向】B7-H3(CD276):双重功能免疫检查点的分子特征与科研应用
476
2026-04-20





